KING OF PRUSSIA, PA. -- CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 monthsHizentra, th

read more>>

GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta® (belimumab) as a potential treatment for systemic lupus erythematosus (SLEA priority review designation is granted

read more>>

TEMPO Interactive, Jakarta -- Health Minister Endang Rahayu Sedyaningsih said those who are going on hajj pilgrimage will be given the meningitis vaccine starting next SeptemberIn July, the Indonesian Ulemas Council has allowed two meningitis vaccines, namely the Menveo Meningococcal produced by N

read more>>

Oslo, Norway -- Clavis Pharma (OSE: CLAVIS), the Norwegian cancer drug development company, announces that it has recruited the first patient into its pivotal Phase III study assessing its lead product elacytarabine in patients with late-stage acute myeloid leukemia (AMLElacytarabine is a novel, p

read more>>

FREMONT, Calif. -- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002,

read more>>

CAMBRIDGE, Mass. -- Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan

read more>>

New York, NY -- Intellect Neurosciences, Inc. (OTCBB: ILNS) a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company

read more>>

CHICAGO -- This summer, more than 55 researchers participating in the Alzheimer's Breakthrough Ride(SM) are cycling relay-style across the country, collecting petition signatures asking Congress to make Alzheimer's disease a national priorityThe public response to the petition has been so overwhel

read more>>

CHICAGO -- Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virusRush is the only site in the Midwest enrolling patie

read more>>

CHICAGO -- The Pulmonary Fibrosis Foundation (PFF) today expressed its support for the 2010 National Pulmonary Fibrosis Awareness Week activities, to be held from September 11-18, 2010 in Washington D.C. National PF Week has been held annually since 2003, and seeks to raises awareness of "This i

read more>>